Defining Value Among Treatment Options
Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.
Read More
Evolving Treatment Strategies for UF and Endometriosis
A panel of experts discuss treatment selection among contraceptive agents and evolving treatment strategies for uterine fibroids and endometriosis.
Economic Burden of Unintended Pregnancy
Payer considerations regarding unintended pregnancy is discussed by Maria Lopes, MD, MS, and Kevin Stephens Sr., MD, JD.
Identifying Risk Factors For UF and Endometriosis
Ayman Al-Hendy, MD, PhD identifies risk factors for development of US and endometriosis.
Drivers of Healthcare Utilization in Women’s Health
Kevin Stephens, Sr. MD, JD examines key drivers of healthcare utilization for women of childbearing years.
A Paradigm Shift in Treatment of UF and Endometriosis
Steven McCarus, MD FACOG highlights the shift away from surgical treatment toward medical therapy in UF and endometriosis.
Payer Considerations in Women’s Reproductive Health
Dr Lopes, OB-GYN and payer, discusses a focus on screening and prevention and availability of contraception among health plans in women’s health.
Common Conditions During Reproductive Years
Ayman Al-Hendy, MD, PhD and Maria Lopes, MD, MS discuss common concerns that women seek care for during their reproductive years, including uterine fibroids, endometriosis, and unintended pregnancy.
